Bansi Nagji - Sep 14, 2021 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Signature
/s/ Gracye Cheng, as Attorney-in-Fact for Bansi Nagji
Stock symbol
GDRX
Transactions as of
Sep 14, 2021
Transactions value $
-$6,872,726
Form type
4
Date filed
9/16/2021, 07:52 PM
Previous filing
Jun 24, 2021
Next filing
Oct 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise $614K +89.8K $6.84 89.8K Sep 14, 2021 Direct
transaction GDRX Class A Common Stock Sale -$4.04M -89.8K -100% $45.01* 0 Sep 14, 2021 Direct F1, F2
transaction GDRX Class A Common Stock Options Exercise $413K +60.4K $6.84 60.4K Sep 15, 2021 Direct
transaction GDRX Class A Common Stock Sale -$2.72M -60.4K -100% $45.03* 0 Sep 15, 2021 Direct F1, F3
transaction GDRX Class A Common Stock Options Exercise $204K +29.8K $6.84 29.8K Sep 16, 2021 Direct
transaction GDRX Class A Common Stock Sale -$1.34M -29.8K -100% $45.03* 0 Sep 16, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Stock Option (Right to Buy) Options Exercise $0 -89.6K -15.69% $0.00 481K Sep 14, 2021 Class A Common Stock 89.8K $6.84 Direct F5
transaction GDRX Stock Option (Right to Buy) Options Exercise $0 -213 -0.05% $0.00 400K Sep 14, 2021 Class A Common Stock 213 $6.84 Direct F6
transaction GDRX Stock Option (Right to Buy) Options Exercise $0 -60.4K -15.11% $0.00 339K Sep 15, 2021 Class A Common Stock 60.4K $6.84 Direct F6
transaction GDRX Stock Option (Right to Buy) Options Exercise $0 -29.8K -8.78% $0.00 310K Sep 16, 2021 Class A Common Stock 29.8K $6.84 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.11. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.24. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.13. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The option has vested and became exercisable or will vest and become exercisable with respect to the original 700,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on June 10, 2020.
F6 The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the shares monthly thereafter until fully vested on June 10, 2024.